Contact: +92 311 11138 38 | Quick Order
Admit (Sitagliptin) is recommended as a monotherapy, combination medication, or in addition to insulin for individuals with type II diabetes mellitus (non-insulin dependent diabetes mellitus) in order to enhance glycemic control.
Customers also bought